The Full Wiki

Serotonin reuptake inhibitor: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

A serotonin reuptake inhibitor (SRI) is a type of drug which acts as a reuptake inhibitor for the neurotransmitter serotonin (5-hydroxytryptamine (5-HT)) by blocking the action of the serotonin transporter (SERT). This in turn leads to increased extracellular concentrations of serotonin and therefore an increase in serotonergic neurotransmission.

SRIs are not synonymous with selective serotonin reuptake inhibitors (SSRIs), as the latter term is usually used to describe the class of antidepressants of the same name, and, because SRIs, unlike SSRIs, can be either selective or nonselective in their action. For example, cocaine, which nonselectively inhibits the reuptake of serotonin, norepinephrine, and dopamine, can obviously be called an SRI, but not an SSRI.



SRIs may be used in the clinical treatment of mood disorders such as major depressive disorder (MDD), dysthymia, and bipolar disorder (BD) as antidepressants, anxiety disorders such as generalized anxiety disorder (GAD), social phobia (SP) also known as social anxiety disorder (SAD), obsessive-compulsive disorder (OCD), and panic disorder (PD) as anxiolytics, post-traumatic stress disorder (PTSD), body dysmorphic disorder (BDD), eating disorders like anorexia nervosa and bulimia nervosa, and certain personality disorders such as borderline personality disorder (BPD), as well as chronic pain, neuralgia or neuropathic pain, and fibromyalgia as analgesics (see duloxetine, milnacipran, and bicifadine), irritable bowel syndrome (IBS) as gastroprokinetic agents, premature ejaculation (PE) (see dapoxetine), drug addiction as anticraving agents, and obesity for anorectic or weight loss purposes (see sibutramine).



SRIs can induce a wide range of psychological and physiological effects, including the following:


It should be noted, however, that many of these effects are dependent on whether the administration of the SRI is acute or chronic. As an example, acute ingestion typically does not result in a mood lift, and chronic administration usually does not result in any sort of psychedelia whatsoever. Additionally, many of these properties are also dependent on whether the SRI in question is capable of crossing the blood-brain-barrier (BBB). Those that do not will only produce peripheral effects.


At very high doses characterized by overdose, serotonin syndrome may develop, resulting in symptoms including the following:


List of SRIs

Pharmaceutical Drugs
Dietary Supplements
Street Drugs
Research Chemicals

See also


  1. ^ a b c Gillman PK. (2005). "Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity.". Br J Anaesth. 95 (4): 434–41. PMID 16051647. 
  2. ^ a b c d Yeh SY, Dersch C, Rothman R, Cadet JL (September 1999). "Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats". Synapse (New York, N.Y.) 33 (3): 207–17. doi:10.1002/(SICI)1098-2396(19990901)33:3<207::AID-SYN5>3.0.CO;2-8. PMID 10420168. 
  3. ^ Werling LL, Keller A, Frank JG, Nuwayhid SJ (2007). "A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder". Exp Neurol. 207 (2): 248–57. PMID 17689532. 
  4. ^ Pharmaceutical compositions containing mesembrine and related compounds. U.S. Patent 6,288,104 (PDF)

Got something to say? Make a comment.
Your name
Your email address